N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide
C67H79FN10O7S2 — CID 176788379
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide
N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide (PubChem CID 176788379) has the molecular formula C67H79FN10O7S2 and a molecular weight of 1219.56 g/mol. Its IUPAC name is N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide.
Molecular Properties
| Compound Name | N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide |
|---|---|
| PubChem CID | 176788379 |
| Molecular Formula | C67H79FN10O7S2 |
| Molecular Weight | 1219.56 g/mol |
| Exact Mass | 1218.56 |
| IUPAC Name | N-(1,3-benzothiazol-2-yl)-2-[5-[1-(cyclohexylmethyl)-5-methylpyrazol-4-yl]-6-[6-[2-[[[(1R,4S)-2-[(2S)-2-[(1-fluorocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxycyclopentanecarbonyl]amino]methyl]-5-(4-methyl-1,3-thiazol-5-yl)phenoxy]hexylcarbamoyl]-2-pyridinyl]-3,4-dihydro-1H-isoquinoline-8-carboxamide |
| SMILES | Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CC2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCCCCCNC(=O)c2nc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)ccc2-c2cnn(CC3CCCCC3)c2C)c1 |
| InChI | InChI=1S/C67H79FN10O7S2/c1-40-59(86-39-71-40)44-22-23-45(35-70-61(81)50-34-46(79)33-49(50)58(80)60(66(3,4)5)75-64(84)67(68)27-28-67)54(32-44)85-31-14-7-6-13-29-69-63(83)57-47(51-36-72-78(41(51)2)37-42-16-9-8-10-17-42)24-25-56(74-57)77-30-26-43-18-15-19-48(52(43)38-77)62(82)76-65-73-53-20-11-12-21-55(53)87-65/h11-12,15,18-25,32,36,39,42,46,49-50,60,79H,6-10,13-14,16-17,26-31,33-35,37-38H2,1-5H3,(H,69,83)(H,70,81)(H,75,84)(H,73,76,82)/t46-,49?,50+,60+/m0/s1 |
| InChIKey | OPPBQPOGENFPRB-BRRRMCKUSA-N |
| XLogP | 11.67 |
| TPSA | 222.66 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1219.56 |
| LogP ≤ 5 | 11.67 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176788379 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.